Prevalence and Cognitive Impact of Medial Temporal Atrophy in a Hospital Stroke Service: Retrospective Cohort Study

Abstract

Background

Cerebrovascular disease and neurodegeneration cause cognitive impairment and frequently coexist.

Aims

Our objectives were to investigate the prevalence and cognitive impact of medial temporal lobe atrophy – a radiological marker often associated with Alzheimer's disease – in a hospital stroke service.

Methods

Retrospective cohort study of patients from a hospital stroke service. Patients assessed for suspected ischemic stroke or transient ischemic attack, irrespective of final diagnosis, underwent neuropsychological testing and magnetic resonance imaging. medial temporal lobe atrophy, white matter hyperintensities, lacunes, and cerebral microbleeds were rated using established criteria and validated scales. The associations between medial temporal lobe atrophy and cognition were tested using multivariable logistic regression analyses, adjusted for age and imaging markers of cerebrovascular disease.

Results

Three hundred and ninety-three patients were included, of whom 169 (43%; 95% confidence interval: 38·1–48·1%) had medial temporal lobe atrophy; in 38 patients (9·7%), medial temporal lobe atrophy was severe (mean score ≥2). In unadjusted logistic regression analyses in the whole cohort, mean medial temporal lobe atrophy score was associated with verbal memory, nominal and perceptual skills, executive function, and speed and attention. After adjustment for age, white matter hyperintensities, number of lacunes, presence of cerebral microbleeds, previous ischemic stroke or transient ischemic attack, and premorbid intelligence quotient, mean medial temporal lobe atrophy score remained associated with impairment in verbal memory (odds ratio: 1·64; 95% confidence interval 1·04–2·58) and nominal skills (odds ratio: 1·61; 95% confidence interval 1·04–2·48).

Conclusions

Medial temporal lobe atrophy is common and has an independent impact on cognitive function in a stroke service population, independent of confounding factors including age and magnetic resonance imaging markers of cerebrovascular disease. Medial temporal lobe atrophy is independently related to verbal memory and nominal skills, while small vessel pathology also contributes to speed and attention, and executive and perceptual functions.

Keywords

cerebral amyloid angiopathy medial temporal lobe atrophy

Get full access to this article

View all access options for this article.

References

Leys

Henon

Mackowiak-Cordoliani

Pasquier

. Post-stroke dementia. Lancet Neurol 2005; 4: 752–9.

Pohjasvaara

Erkinjuntti

Vataja

Kaste

. Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke 1997; 28: 785–92.

Gorelick

Scuteri

Black

. Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 2672–713.

Schneider

Arvanitakis

Bang

Bennett

. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007; 69: 2197–204.

MRC-CFAS. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001; 357: 169–75.

Heyman

Fillenbaum

Welsh-Bohmer

. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 1998; 51: 159–62.

Kalaria

Ballard

. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1999; 13(Suppl. 3): S115–23.

Etiene

Kraft

Ganju

. Cerebrovascular pathology contributes to the heterogeneity of Alzheimer's disease. J Alzheimers Dis 1998; 1: 119–34.

Smith

Greenberg

. Beta-amyloid, blood vessels, and brain function. Stroke 2009; 40: 2601–6.

10.

Hulette

Nochlin

McKeel

. Clinical-neuropathologic findings in multi-infarct dementia: A report of six autopsied cases. Neurology 1997; 48: 668–72.

11.

Fotuhi

Hachinski

Whitehouse

. Changing perspectives regarding late-life dementia. Nat Rev Neurol 2009; 5: 649–58.

12.

Frisoni

Fox

Jack

Jr Scheltens

Thompson

. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 2010; 6: 67–77.

13.

Scheltens

Van der Pol

. Impact commentaries. Atrophy of medial temporal lobes on MRI in ‘probable’ Alzheimer's disease and normal ageing: Diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 2012; 83: 1038–40.

14.

Scheltens

Leys

Barkhof

. Atrophy of medial temporal lobes on MRI in ‘probable’ Alzheimer's disease and normal ageing: Diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55: 967–72.

15.

Kril

Patel

Harding

Halliday

. Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss. J Neurol Neurosurg Psychiatry 2002; 72: 747–51.

16.

Bastos-Leite

Van der Flier

Van Straaten

Staekenborg

Scheltens

Barkhof

. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke 2007; 38: 3182–5.

17.

Schuff

Laakso

. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology 2002; 58: 1635–41.

18.

O'Sullivan

Ngo

Viswanathan

. Hippocampal volume is an independent predictor of cognitive performance in CADASIL. Neurobiol Aging 2009; 30: 890–7.

19.

Adams

Jr Bendixen

Kappelle

. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35–41.

20.

Werring

Frazer

Coward

. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 2004; 127(Pt 10):2265–75.

21.

Gavrilescu

Kase

. Clinical stroke syndromes: Clinical-anatomical correlations. Cerebrovasc Brain Metab Rev 1995; 7: 218–39.

22.

Potter

Doubal

Jackson

. Counting cavitating lacunes underestimates the burden of lacunar infarction. Stroke 2010; 41: 267–72.

23.

Wahlund

Barkhof

Fazekas

. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001; 32: 1318–22.

24.

Gregoire

Chaudhary

Brown

. The Microbleed Anatomical Rating Scale (MARS): Reliability of a tool to map brain microbleeds. Neurology 2009; 73: 1759–66.

25.

Landis

Koch

. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–74.

26.

Von Elm

Altman

Egger

Pocock

Gotzsche

Vandenbroucke

. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. PLoS Med 2007; 4: e296.

27.

Henon

Pasquier

Durieu

Pruvo

Leys

. Medial temporal lobe atrophy in stroke patients: Relation to pre-existing dementia. J Neurol Neurosurg Psychiatry 1998; 65: 641–7.

28.

Cordoliani-Mackowiak

Henon

Pruvo

Pasquier

Leys

. Post-stroke dementia: Influence of hippocampal atrophy. Arch Neurol 2003; 60: 585–90.

29.

Jokinen

Kalska

Ylikoski

. Medial temporal lobe atrophy and memory deficits in elderly stroke patients. Eur J Neurol 2004; 11: 825–32.

30.

Iadecola

. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol 2010; 120: 287–96.

31.

O'Brien

Desmond

Ames

Schweitzer

Tress

. Magnetic resonance imaging correlates of memory impairment in the healthy elderly: Association with medial temporal lobe atrophy but not white matter lesions. Int J Geriatr Psychiatry 1997; 12: 369–74.

32.

Mizuno

Wakai

Takeda

Sobue

. Medial temporal atrophy and memory impairment in early stage of Alzheimer's disease: An MRI volumetric and memory assessment study. J Neurol Sci 2000; 173: 18–24.

33.

Mori

Yoneda

Yamashita

Hirono

Ikeda

Yamadori

. Medial temporal structures relate to memory impairment in Alzheimer's disease: An MRI volumetric study. J Neurol Neurosurg Psychiatry 1997; 63: 214–21.

34.

Pendlebury

Rothwell

. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: A systematic review and meta-analysis. Lancet Neurol 2009; 8: 1006–18.

35.

Aggarwal

Decarli

. Vascular dementia: Emerging trends. Semin Neurol 2007; 27: 66–77.

36.

Roman

Salloway

Black

. Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: Differential effects by hippocampal size. Stroke 2010; 41: 1213–21.

37.

Ally

Gold

Budson

. The picture superiority effect in patients with Alzheimer's disease and mild cognitive impairment. Neuropsychologia 2009; 47: 595–8.

38.

Epelbaum

Benisty

Reyes

. Verbal memory impairment in subcortical ischemic vascular disease: A descriptive analysis in CADASIL. Neurobiol Aging 2011; 32: 2172–82.

39.

Henderson

Mack

Freed

Kempler

Andersen

. Naming consistency in Alzheimer's disease. Brain Lang 1990; 39: 530–8.

40.

Appel

Potter

Bhatia

. Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors. AJNR Am J Neuroradiol 2009; 30: 1870–6.

41.

Nordberg

Rinne

Kadir

Langstrom

. The use of PET in Alzheimer disease. Nat Rev Neurol 2010; 6: 78–87.

42.

Charidimou

Gang

Werring

. Sporadic cerebral amyloid angiopathy revisited: Recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 2012; 83: 124–37.